Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 183 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

A Study of Zigakibart in Adults With IgA Nephropathy

 		IgA Nephropathy, Immunoglobulin A Nephropathy Phase3 Argentina
Australia
Belgium
Brazil
Canada
China
Croatia
Czechia
France
Germany
Greece
India
Israel
Italy
Japan
Korea, Republic of
Malaysia
Mexico
Spain
Taiwan
Turkey
United Kingdom
United States
View All
 NCT05852938

A Study to Investigate the Safety, Tolerability and Preliminary Efficacy of NGI226 Microparticles in Patients With Achilles Tendinopathy

 		Achilles Tendinopathy Phase2 France
Germany
United States 		NCT05592990

Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

 		Atypical Hemolytic Uremic Syndrome Phase3 China
France
Germany
Italy
Japan
Spain
Turkey
United Kingdom
View All
 NCT05935215

Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.

 		Lymphatic Malformations Phase2, Phase3 Australia
Belgium
France
Germany
Italy
Spain
United States
View All
 NCT05948943

A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines

 		Chronic Inducible Urticaria Phase3 Argentina
Australia
Brazil
Canada
France
India
Italy
Japan
Singapore
Slovakia
Spain
Turkey
United States
Vietnam
View All
 NCT05976243

Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia

 		Myeloid Leukemia, Philadelphia Positive Phase1, Phase2 China
France
Germany
Greece
Hungary
Italy
Japan
Korea, Republic of
Netherlands
Poland
Russian Federation
Thailand
Turkey
United States
View All
 NCT04925479

Ofatumumab in Portuguese Multiple Sclerosis Patients - an Observational Study

 		Relapsing Multiple Sclerosis Portugal NCT05809986

A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)

 		Renal Angiomyolipoma Phase4 Taiwan NCT05252585

Early Versus Late Ofatumumab (Kesimpta®) Use in Austrian RMS-Patients Over 2 Years

 		Relapsing Multiple Sclerosis Austria NCT05776888

Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) in Routine Clinical Practice in the Russian Federation

 		Hidradenitis Suppurativa Russian Federation NCT06517732